BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -12.17% -4.65% -23.66% -4.65% -14.82% -7.50% 1.19% -4.67% 13.38% 04/07/2010
BIB NAV -12.25% -4.72% -23.81% -4.72% -14.95% -7.45% 1.07% -4.69% 13.36% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/23/2025
  • NAV
    $44.41
  • NAV Change
    $+1.43 up caret
  • Market Price
    $44.35
  • Market Price Change
    $+1.30 up caret
  • Trading Volume (M)
    18,972
  • 30-Day Median Bid Ask Spread
    0.36%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/23/2025
  • NAV
    $44.41
  • NAV Change
    $+1.43 up caret
  • Market Price
    $44.35
  • Market Price Change
    $+1.30 up caret
  • Trading Volume (M)
    18,972
  • 30-Day Median Bid Ask Spread
    0.36%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2025

Holdings

as of 4/23/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
6.73% VRTX VERTEX PHARMACEUTICALS INC -- $3,287,888.34 6,677 2931034
6.10% GILD GILEAD SCIENCES INC -- $2,981,299.50 28,025 2369174
5.92% AMGN AMGEN INC -- $2,889,882.10 10,399 2023607
5.17% REGN REGENERON PHARMACEUTICALS -- $2,524,815.75 4,295 2730190
3.26% AZN ASTRAZENECA PLC-SPONS ADR -- $1,593,748.13 23,263 2989044
2.56% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,251,468.84 5,172 B00FWN1
2.00% SMMT SUMMIT THERAPEUTICS INC -- $979,288.10 29,470 BMTVQS7
1.56% ARGX ARGENX SE - ADR -- $759,962.70 1,278 BDVLM39
1.41% BIIB BIOGEN INC -- $690,939.99 5,847 2455965
1.25% SNY SANOFI-ADR -- $608,616.58 11,479 2964557
1.12% RPRX ROYALTY PHARMA PLC- CL A -- $548,617.28 17,312 BMVP7Y0
1.08% UTHR UNITED THERAPEUTICS CORP -- $526,760.70 1,795 2430412
1.05% INSM INSMED INC -- $511,954.80 7,231 2614487
0.99% ILMN ILLUMINA INC -- $482,510.00 6,328 2613990
0.97% BMRN BIOMARIN PHARMACEUTICAL INC -- $472,044.74 7,621 2437071
0.93% BNTX BIONTECH SE-ADR -- $456,449.25 3,975 BK6H543
0.92% INCY INCYTE CORP -- $448,398.00 7,731 2471950
0.85% ONC BEIGENE LTD-ADR -- $416,545.36 1,672 BYYWPW6
0.84% EXEL EXELIXIS INC -- $411,237.18 11,181 2576941
0.84% NBIX NEUROCRINE BIOSCIENCES INC -- $411,228.48 3,984 2623911
0.84% MRNA MODERNA INC -- $409,061.02 15,413 BGSXTS3
0.78% ASND ASCENDIS PHARMA A/S - ADR -- $381,433.68 2,412 BV9G6B8
0.76% VTRS VIATRIS INC -- $372,435.47 47,687 BMWS3X9
0.72% MEDP MEDPACE HOLDINGS INC -- $353,587.18 1,217 BDCBC61
0.68% TEM TEMPUS AI INC -- $330,944.45 6,679 BSLSJJ0
0.63% ROIV ROIVANT SCIENCES LTD -- $306,154.44 28,506 BMW4NZ9
0.59% HALO HALOZYME THERAPEUTICS INC -- $287,377.20 4,920 2975098
0.57% RVMD REVOLUTION MEDICINES INC -- $278,066.88 7,427 BL71K91
0.56% MDGL MADRIGAL PHARMACEUTICALS INC -- $272,352.78 882 BD59BS7
0.55% BBIO BRIDGEBIO PHARMA INC -- $267,677.54 7,598 BK1KWG8
0.52% JAZZ JAZZ PHARMACEUTICALS PLC -- $252,764.94 2,426 B4Q5ZN4
0.47% SRPT SAREPTA THERAPEUTICS INC -- $230,642.73 3,877 B8DPDT7
0.46% GH GUARDANT HEALTH INC -- $225,050.84 4,931 BFXC911
0.45% BPMC BLUEPRINT MEDICINES CORP -- $219,072.93 2,553 BWY52P3
0.42% ADMA ADMA BIOLOGICS INC -- $205,196.39 9,443 B9NSBM2
0.42% AXSM AXSOME THERAPEUTICS INC -- $203,040.04 1,948 BYZR4X4
0.41% VRNA VERONA PHARMA PLC - ADR -- $199,299.88 3,148 BYWPZK5
0.39% NUVL NUVALENT INC-A -- $192,172.53 2,643 BMVBZD3
0.39% KRYS KRYSTAL BIOTECH INC -- $190,835.80 1,151 BD6JX35
0.38% IONS IONIS PHARMACEUTICALS INC -- $184,814.10 6,351 BDJ0LS6
0.37% CYTK CYTOKINETICS INC -- $179,740.00 4,730 BBBSBJ5
0.36% ALKS ALKERMES PLC -- $176,366.40 6,496 B3P6D26
0.35% PCVX VAXCYTE INC -- $170,575.04 5,144 BKPVGH6
0.32% PTCT PTC THERAPEUTICS INC -- $157,392.45 3,151 B17VCN9
0.31% RYTM RHYTHM PHARMACEUTICALS INC -- $151,155.84 2,526 BF2YWG4
0.30% RNA AVIDITY BIOSCIENCES INC -- $147,325.36 4,802 BMWHPY1
0.29% ACLX ARCELLX INC -- $139,667.85 2,195 BPCJ1Q2
0.28% RARE ULTRAGENYX PHARMACEUTICAL IN -- $137,897.76 3,696 BJ62Z18
0.27% CRSP CRISPR THERAPEUTICS AG -- $132,076.58 3,427 BDHF4K6
0.26% AKRO AKERO THERAPEUTICS INC -- $125,999.41 3,181 BK7Y2V9
0.25% SWTX SPRINGWORKS THERAPEUTICS INC -- $123,382.74 2,994 BGMGM89
0.25% SRRK SCHOLAR ROCK HOLDING CORP -- $122,990.64 3,782 BFZQ0L8
0.25% CRNX CRINETICS PHARMACEUTICALS IN -- $120,351.66 3,718 BDD19F8
0.24% MRUS MERUS NV -- $115,492.63 2,761 BZBY005
0.24% XENE XENON PHARMACEUTICALS INC -- $114,950.22 3,058 BRJ3GY4
0.23% PTGX PROTAGONIST THERAPEUTICS INC -- $113,184.32 2,452 BDCBCD8
0.23% LEGN LEGEND BIOTECH CORP-ADR -- $111,955.20 3,264 BMX9K07
0.21% ALVO ALVOTECH SA -- $100,687.84 12,044 BPNTJ34
0.20% IMVT IMMUNOVANT INC -- $98,057.70 6,786 BJRFSB7
0.20% VCYT VERACYTE INC -- $97,950.55 3,113 BFTWZY0
0.20% ACAD ACADIA PHARMACEUTICALS INC -- $97,413.06 6,663 2713317
0.19% AMRX AMNEAL PHARMACEUTICALS INC -- $90,395.90 12,383 BFNF1D6
0.18% TWST TWIST BIOSCIENCE CORP -- $89,648.46 2,383 BGKG6G7
0.18% RXRX RECURSION PHARMACEUTICALS-A -- $88,069.14 15,783 BM9FJ13
0.18% APLS APELLIS PHARMACEUTICALS INC -- $87,712.35 5,015 BYTQ6X1
0.18% FOLD AMICUS THERAPEUTICS INC -- $87,145.40 12,274 B19FQ48
0.18% DNLI DENALI THERAPEUTICS INC -- $86,260.87 5,801 BD2B4V0
0.17% ZLAB ZAI LAB LTD-ADR -- $84,016.38 2,499 BD9GVY0
0.17% LGND LIGAND PHARMACEUTICALS -- $81,329.44 769 2501578
0.16% VCEL VERICEL CORP -- $79,939.80 1,996 BSBMN89
0.16% KYMR KYMERA THERAPEUTICS INC -- $79,635.80 2,594 BMPRZV5
0.16% IBRX IMMUNITYBIO INC -- $78,467.30 29,170 BNSP0B8
0.16% NVCR NOVOCURE LTD -- $78,028.07 4,391 BYSS4X4
0.16% MIRM MIRUM PHARMACEUTICALS INC -- $77,575.96 1,958 BJDX8Y8
0.16% TARS TARSUS PHARMACEUTICALS INC -- $76,700.00 1,534 BMH5RL1
0.16% -- NEWAMSTERDAM PHARMA CO NV -- $75,763.49 4,387 BP8JSP4
0.15% JANX JANUX THERAPEUTICS INC -- $74,654.82 2,361 BMFX8Y7
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $68,773.20 2,230 B72ZBG4
0.14% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $68,493.00 4,740 BKX9VD3
0.14% BCRX BIOCRYST PHARMACEUTICALS INC -- $66,450.08 8,348 2100362
0.14% BEAM BEAM THERAPEUTICS INC -- $66,425.41 3,343 BK6L288
0.14% HRMY HARMONY BIOSCIENCES HOLDINGS -- $66,209.90 2,291 BKSGZN7
0.13% IDYA IDEAYA BIOSCIENCES INC -- $65,813.54 3,497 BK0VHF6
0.13% APGE APOGEE THERAPEUTICS INC -- $65,680.94 1,798 BM9HHL5
0.13% ARWR ARROWHEAD PHARMACEUTICALS IN -- $65,544.38 5,038 BYQBFJ8
0.13% AGIO AGIOS PHARMACEUTICALS INC -- $64,938.93 2,289 BCBVTX1
0.13% CGON CG ONCOLOGY INC -- $63,039.93 3,041 BRBCSP4
0.13% IRON DISC MEDICINE INC -- $62,352.15 1,381 BMGJZJ8
0.12% ANIP ANI PHARMACEUTICALS INC -- $59,413.53 869 BCDWBX6
0.12% TVTX TRAVERE THERAPEUTICS INC -- $59,218.20 3,546 BLFGJD5
0.12% VERA VERA THERAPEUTICS INC -- $56,899.98 2,547 BL55460
0.11% EWTX EDGEWISE THERAPEUTICS INC -- $56,101.89 3,783 BKY5JZ8
0.11% MNKD MANNKIND CORP -- $55,914.69 12,129 BF081J4
0.11% SPRY ARS PHARMACEUTICALS INC -- $55,837.54 3,883 BMCR7V2
0.11% GPCR STRUCTURE THERAPEUTICS INC -- $55,501.60 2,380 BQS9486
0.11% DVAX DYNAVAX TECHNOLOGIES CORP -- $53,376.12 4,956 BRJZSK0
0.10% OCUL OCULAR THERAPEUTIX INC -- $49,298.00 6,280 BNZB1X8
0.10% DYN DYNE THERAPEUTICS INC -- $48,714.82 4,519 BN15WD1
0.10% NVAX NOVAVAX INC -- $48,002.22 6,426 BJDQXG4
0.10% CNTA CENTESSA PHARMACEUTICALS-ADR -- $47,520.41 3,647 BLB0YQ9
0.10% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $47,173.40 1,583 BLCD809
0.10% INDV INDIVIOR PLC -- $46,862.55 4,959 BP0BQQ5
0.10% PCRX PACIRA BIOSCIENCES INC -- $46,594.80 1,849 B3X26D8
0.09% ARDX ARDELYX INC -- $46,181.70 9,522 BN89V40
0.09% INVA INNOVIVA INC -- $45,980.11 2,503 BDDXF67
0.09% GRAL GRAIL INC -- $45,339.68 1,343 BSLSSX7
0.09% AMPH AMPHASTAR PHARMACEUTICALS IN -- $45,258.76 1,921 BNFWZS4
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $44,381.74 5,486 BFWLC09
0.09% SNDX SYNDAX PHARMACEUTICALS INC -- $44,330.00 3,410 BN7Q7R7
0.09% ADPT ADAPTIVE BIOTECHNOLOGIES -- $43,512.48 5,896 BJ5FZ74
0.09% IOVA IOVANCE BIOTHERAPEUTICS INC -- $41,785.81 13,099 BF0DMK7
0.08% WVE WAVE LIFE SCIENCES LTD -- $41,371.47 6,093 BYZG9R0
0.08% ETNB 89BIO INC -- $38,607.84 5,832 BK1K484
0.07% GERN GERON CORP -- $35,367.16 25,444 2370381
0.07% NRIX NURIX THERAPEUTICS INC -- $35,189.91 3,031 BMVLGP2
0.07% GRFS GRIFOLS SA-ADR -- $35,036.87 4,873 B8K7T65
0.07% KNSA KINIKSA PHARMACEUTICALS INTE -- $35,036.64 1,678 BRXB0C0
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $34,687.04 1,952 BMFD115
0.07% TXG 10X GENOMICS INC-CLASS A -- $34,664.88 4,325 BKS3RS7
0.07% ZYME ZYMEWORKS INC -- $34,262.40 2,752 BPCQZY9
0.07% SYRE SPYRE THERAPEUTICS INC -- $34,241.76 2,408 BQBBDY8
0.07% HROW HARROW INC -- $33,910.09 1,423 BHNDW86
0.07% GMAB GENMAB A/S -SP ADR -- $33,717.75 1,675 BBC9WC7
0.07% NTLA INTELLIA THERAPEUTICS INC -- $33,460.24 4,136 BYZM6C2
0.07% VIR VIR BIOTECHNOLOGY INC -- $32,709.63 5,479 BK4PZ38
0.07% COLL COLLEGIUM PHARMACEUTICAL INC -- $32,695.42 1,258 BX7RSN3
0.07% AVDL AVADEL PHARMACEUTICALS -- $31,993.50 3,850 BDGMC59
0.06% AVXL ANAVEX LIFE SCIENCES CORP -- $31,635.38 3,398 BYTYP72
0.06% QURE UNIQURE NV -- $31,082.40 2,160 BJFSR88
0.06% XNCR XENCOR INC -- $30,599.05 2,815 BGCYWN8
0.06% RCKT ROCKET PHARMACEUTICALS INC -- $30,409.26 4,259 BDFKQ07
0.06% DAWN DAY ONE BIOPHARMACEUTICALS I -- $30,124.56 4,049 BLB0YH0
0.06% ABCL ABCELLERA BIOLOGICS INC -- $30,117.12 11,904 BL53SR3
0.06% LENZ LENZ THERAPEUTICS INC -- $29,591.10 1,098 BQV0J03
0.06% PRAX PRAXIS PRECISION MEDICINES I -- $29,491.54 806 BQ721R4
0.06% EOLS EVOLUS INC -- $28,411.90 2,530 BDRJH21
0.06% CVAC CUREVAC NV -- $28,409.54 8,962 BN4RD42
0.06% AVBP ARRIVENT BIOPHARMA INC -- $28,394.76 1,347 BMGTLY5
0.06% REPL REPLIMUNE GROUP INC -- $27,169.91 3,077 BDDVW37
0.06% MLYS MINERALYS THERAPEUTICS INC -- $26,938.23 1,991 BP9N0G0
0.05% ANAB ANAPTYSBIO INC -- $25,014.50 1,225 BDRW1L7
0.05% ARVN ARVINAS INC -- $24,924.36 2,748 BDZ30Q0
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $24,598.28 5,956 BLR7H87
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $24,576.30 1,974 BD06CS0
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $24,526.80 7,570 BZ0QMB7
0.05% CSTL CASTLE BIOSCIENCES INC -- $24,226.53 1,139 BKLCWZ3
0.05% KROS KEROS THERAPEUTICS INC -- $23,180.30 1,621 BM7V485
0.05% TRVI TREVI THERAPEUTICS INC -- $22,383.90 3,570 BJH9ZN0
0.05% SVRA SAVARA INC -- $22,282.00 6,856 BYXGN81
0.04% RLAY RELAY THERAPEUTICS INC -- $21,064.03 6,773 BN2R582
0.04% PRTA PROTHENA CORP PLC -- $20,618.50 2,150 B91XRN2
0.04% KURA KURA ONCOLOGY INC -- $20,549.62 3,226 BYZD465
0.04% CRMD CORMEDIX INC -- $20,482.80 2,424 BJ0LT31
0.04% COGT COGENT BIOSCIENCES INC -- $20,329.56 4,548 BLR6XK8
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $20,261.78 3,122 BFYQFJ2
0.04% TYRA TYRA BIOSCIENCES INC -- $20,260.44 2,022 BMVNDH9
0.04% STOK STOKE THERAPEUTICS INC -- $20,144.32 2,116 BJQ05Z6
0.04% CGEM CULLINAN THERAPEUTICS INC -- $19,584.06 2,337 BM90J52
0.04% VERV VERVE THERAPEUTICS INC -- $19,407.56 3,548 BNKGXX2
0.04% FTRE FORTREA HOLDINGS INC -- $19,061.56 3,583 BRXYZ57
0.04% PGEN PRECIGEN INC -- $18,954.00 11,700 BKM5C84
0.04% HCM HUTCHMED CHINA-ADR -- $18,832.80 1,239 BYXV9H7
0.04% SAGE SAGE THERAPEUTICS INC -- $18,714.72 2,456 BP4GNK9
0.04% TBPH THERAVANCE BIOPHARMA INC -- $18,569.25 1,965 BMNDK09
0.04% EYPT EYEPOINT PHARMACEUTICALS INC -- $18,298.17 2,727 BMGS7L1
0.04% TRML TOURMALINE BIO INC -- $18,247.68 1,024 BQ80NC6
0.04% MNMD MIND MEDICINE MINDMED INC -- $17,902.30 2,930 BPQYY97
0.04% SIGA SIGA TECHNOLOGIES INC -- $17,796.48 2,852 2107437
0.04% RGNX REGENXBIO INC -- $17,553.73 1,979 BZ0G875
0.04% AMLX AMYLYX PHARMACEUTICALS INC -- $17,320.38 3,423 BPCK358
0.04% URGN UROGEN PHARMA LTD -- $17,197.20 1,686 BZ7PJQ1
0.03% RAPP RAPPORT THERAPEUTICS INC -- $16,626.18 1,461 BR3T9B6
0.03% OMER OMEROS CORP -- $16,135.55 2,315 B4NB858
0.03% ERAS ERASCA INC -- $16,038.90 11,295 BNLYBF3
0.03% ORKA ORUKA THERAPEUTICS INC -- $15,827.68 1,496 BKVF0J2
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $15,464.25 2,133 BLFBZ32
0.03% ALT ALTIMMUNE INC -- $15,292.69 3,077 BFY7DC4
0.03% SANA SANA BIOTECHNOLOGY INC -- $15,251.49 8,919 BMFJJ97
0.03% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $15,250.53 1,759 BKDQKM6
0.03% MESO MESOBLAST LTD- SPON ADR -- $15,084.90 1,359 BQS7491
0.03% TSHA TAYSHA GENE THERAPIES INC -- $14,905.80 8,190 BNC1BX1
0.03% GLPG GALAPAGOS NV-SPON ADR -- $14,892.00 584 B292NQ7
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $14,859.66 2,966 BMZ4LN0
0.03% ORIC ORIC PHARMACEUTICALS INC -- $14,672.46 2,838 BKVDFF7
0.03% ABSI ABSCI CORP -- $14,638.91 4,589 BN94K69
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $13,983.60 813 BL95N25
0.03% TKNO ALPHA TEKNOVA INC -- $13,695.90 2,130 BP7L561
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $13,687.30 1,082 BKC9SX3
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $13,485.36 8,376 BFZNYB7
0.03% TRDA ENTRADA THERAPEUTICS INC -- $13,082.42 1,502 BP81RK8
0.03% GLUE MONTE ROSA THERAPEUTICS INC -- $13,079.82 2,454 BP7KZP7
0.03% PSNL PERSONALIS INC -- $12,975.68 3,526 BJQ0608
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $12,800.97 10,941 B4N8MH9
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $12,784.64 704 BQD3J33
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $12,090.57 8,007 BFMLGR4
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $11,898.60 5,666 BMCWKZ2
0.02% MXCT MAXCYTE INC -- $11,841.34 4,214 BKMQF66
0.02% RNAC CARTESIAN THERAPEUTICS INC -- $11,804.45 1,015 BQB9HM8
0.02% ATXS ASTRIA THERAPEUTICS INC -- $11,720.80 2,254 BMYRFN8
0.02% TECX TECTONIC THERAPEUTIC INC -- $11,509.06 589 BPBPCG8
0.02% AURA AURA BIOSCIENCES INC -- $11,491.20 1,995 BP81R42
0.02% PHAT PHATHOM PHARMACEUTICALS INC -- $10,982.64 2,732 BJLKVS6
0.02% SLDB SOLID BIOSCIENCES INC -- $10,854.44 3,049 BQHN6C7
0.02% ITOS ITEOS THERAPEUTICS INC -- $10,431.85 1,459 BMWXFT4
0.02% FHTX FOGHORN THERAPEUTICS INC -- $10,398.96 2,222 BMF7DT9
0.02% TSVT 2SEVENTY BIO INC -- $10,279.40 2,060 BMTXV88
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $10,270.44 3,642 BYVQJ96
0.02% VNDA VANDA PHARMACEUTICALS INC -- $10,084.57 2,329 B12W3P6
0.02% CMPS COMPASS PATHWAYS PLC -- $9,874.38 2,481 BMC3HS7
0.02% TERN TERNS PHARMACEUTICALS INC -- $9,771.84 3,393 BMDJ0C9
0.02% LXRX LEXICON PHARMACEUTICALS INC -- $9,701.46 14,441 BWFZX59
0.02% AVIR ATEA PHARMACEUTICALS INC -- $9,618.75 3,375 BLN9Z50
0.02% PRME PRIME MEDICINE INC -- $9,327.20 5,240 BPBJFM7
0.02% THRD THIRD HARMONIC BIO INC -- $9,270.00 1,800 BNNPQY8
0.02% DSGN DESIGN THERAPEUTICS INC -- $9,206.34 2,262 BMFK3H6
0.02% NGNE NEUROGENE INC -- $9,155.92 593 BS2F741
0.02% SLRN ACELYRIN INC -- $9,051.75 4,023 BQPF874
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $9,035.84 2,567 BYP80F1
0.02% OABI OMNIAB INC -- $8,944.75 4,835 BN13S71
0.02% ALMS ALUMIS INC -- $8,883.06 1,886 BPLQG36
0.02% CRGX CARGO THERAPEUTICS INC -- $8,367.45 1,839 BQHN2F2
0.02% -- AMARIN CORP PLC ADR USD 10 -- $8,288.00 800 --
0.02% ANNX ANNEXON INC -- $7,834.72 4,258 BMVV9R5
0.02% VYGR VOYAGER THERAPEUTICS INC -- $7,615.18 2,182 BY7RB53
0.02% HUMA HUMACYTE INC -- $7,555.80 5,140 BMYTJP4
0.02% CDXS CODEXIS INC -- $7,544.52 3,309 B5LL2C2
0.02% ESPR ESPERION THERAPEUTICS INC -- $7,471.15 7,871 BBNBTD2
0.02% YMAB Y-MABS THERAPEUTICS INC -- $7,374.80 1,790 BG31GH0
0.01% TVGN TEVOGEN BIO HOLDINGS INC -- $7,132.86 6,993 BPG5P75
0.01% INBX INHIBRX BIOSCIENCES INC -- $7,028.48 578 BNSP8K3
0.01% TNGX TANGO THERAPEUTICS INC -- $6,348.93 4,319 BP2P6L0
0.01% FDMT 4D MOLECULAR THERAPEUTICS IN -- $6,327.00 1,850 BKLXFX5
0.01% ACIU AC IMMUNE SA -- $6,242.58 3,951 BZC0D70
0.01% SLN SILENCE THERAPEUTICS PLC-ADR -- $6,238.28 1,879 BL5B6Z1
0.01% NKTX NKARTA INC -- $6,145.42 2,819 BK80YJ8
0.01% FATE FATE THERAPEUTICS INC -- $6,120.66 4,602 BCZS820
0.01% LRMR LARIMAR THERAPEUTICS INC -- $5,760.74 2,549 BMXNGZ6
0.01% LYEL LYELL IMMUNOPHARMA INC -- $5,579.22 11,672 BN6MB18
0.01% SCPH SCPHARMACEUTICALS INC -- $5,197.40 1,999 BYX2Z16
0.01% EDIT EDITAS MEDICINE INC -- $5,143.32 3,297 BZ8FPH3
0.01% IRWD IRONWOOD PHARMACEUTICALS INC -- $4,951.38 6,393 B3MZ6K5
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $4,771.20 852 B9L5200
0.01% ALEC ALECTOR INC -- $4,592.44 3,959 BJ4LDC4
0.01% NMRA NEUMORA THERAPEUTICS INC -- $4,588.15 6,454 BN4JN37
0.01% CCCC C4 THERAPEUTICS INC -- $4,565.96 2,836 BKX9NQ0
0.01% LXEO LEXEO THERAPEUTICS INC -- $4,502.32 1,336 BQ6C357
0.01% MGNX MACROGENICS INC -- $4,286.97 2,507 BFDV8K0
0.01% PLRX PLIANT THERAPEUTICS INC -- $3,743.74 2,431 BMDWW66
0.01% KYTX KYVERNA THERAPEUTICS INC -- $3,672.12 1,724 BSMLR16
0.01% CLYM CLIMB BIO INC -- $3,597.90 2,685 BMW5LX6
0.01% TCRX TSCAN THERAPEUTICS INC -- $3,198.06 1,962 BNLYBJ7
0.01% BMEA BIOMEA FUSION INC -- $2,980.82 1,447 BNKF6N0
0.01% STRO SUTRO BIOPHARMA INC -- $2,964.60 3,294 BF12XC2
0.01% PYXS PYXIS ONCOLOGY INC -- $2,566.08 2,376 BLBR8D5
0.01% INZY INOZYME PHARMA INC -- $2,517.20 2,567 BMVLGY1
0.01% ACRV ACRIVON THERAPEUTICS INC -- $2,488.00 1,244 BP2TPK4
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $2,376.50 970 BMF1LJ7
-- PEPG PEPGEN INC -- $2,102.66 1,306 BMTX3D7
-- MRSN MERSANA THERAPEUTICS INC -- $1,924.65 4,935 BF3NP05
-- IGMS IGM BIOSCIENCES INC -- $1,891.79 1,361 BKS3SM8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- APLT APPLIED THERAPEUTICS INC -- $1,719.76 4,648 BJL38Z1
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,410.36 511 BT7KGT6
-- QTTB Q32 BIO INC -- $923.40 486 BS2FKQ4
27.60% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 13,484,507 -- 3,276 --
26.00% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 12,702,439 -- 3,086 --
25.68% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 12,546,025 -- 3,048 --
20.39% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 9,961,083 -- 2,420 --
17.33% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 8,466,921 -- 2,057 --
9.49% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 4,634,785 -- 1,126 --
-- -- TREASURY BILL -- $7,471,228.13 7,500,000 BQC9631
-- -- TREASURY BILL -- $3,987,871.00 4,000,000 BSZBFQ4
-- -- TREASURY BILL -- $2,981,100.00 3,000,000 BSNQ2D7
-- -- TREASURY BILL -- $744,480.94 750,000 BS60BF1
-- -- NET OTHER ASSETS (LIABILITIES) -- $-2,249,749.82 -2,249,750 --

Index

as of 3/31/2025

  • Total Number of Companies264
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.80 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.